Bill 118 hr 4881, also known as the "Medicare Drug Cost Sharing Limitation Act," aims to make changes to the Medicare program in order to limit the amount that beneficiaries have to pay for prescription drugs. The bill specifically focuses on amending title XVIII of the Social Security Act, which governs Medicare.
Under the proposed legislation, there would be a cap placed on the amount of cost sharing that Medicare beneficiaries would have to pay for their prescription drugs. This would help to alleviate the financial burden that many seniors and individuals with disabilities face when trying to afford necessary medications.
The bill is designed to ensure that Medicare beneficiaries have access to affordable prescription drugs, while also working to control overall healthcare costs. By limiting cost sharing for drugs, the hope is that individuals will be more likely to adhere to their prescribed medication regimens, leading to better health outcomes and potentially reducing the need for more costly medical interventions down the line.
Overall, the "Medicare Drug Cost Sharing Limitation Act" seeks to improve the affordability and accessibility of prescription drugs for Medicare beneficiaries, ultimately aiming to improve the overall health and well-being of those enrolled in the program.